Genprex, Inc.
GNPX
$0.285
-$0.025-8.07%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 10.63M | 11.39M | 12.99M | 12.19M | 13.43M |
| Depreciation & Amortization | 6.80K | 9.70K | 12.10K | 13.60K | 14.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.17M | 22.81M | 26.27M | 27.79M | 31.06M |
| Operating Income | -21.17M | -22.81M | -26.27M | -27.79M | -31.06M |
| Income Before Tax | -21.39M | -22.71M | -26.14M | -27.63M | -30.86M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.39 | -22.71 | -26.14 | -27.63 | -30.86 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.39M | -22.71M | -26.14M | -27.63M | -30.86M |
| EBIT | -21.17M | -22.81M | -26.27M | -27.79M | -31.06M |
| EBITDA | -21.17M | -22.80M | -26.26M | -27.78M | -31.04M |
| EPS Basic | -8.45 | -11.91 | -16.04 | -19.18 | -22.93 |
| Normalized Basic EPS | -5.26 | -7.45 | -10.03 | -11.99 | -14.33 |
| EPS Diluted | -8.45 | -11.91 | -16.04 | -19.18 | -22.93 |
| Normalized Diluted EPS | -5.26 | -7.45 | -10.03 | -11.99 | -14.33 |
| Average Basic Shares Outstanding | 16.01M | 8.77M | 6.71M | 5.85M | 5.47M |
| Average Diluted Shares Outstanding | 16.01M | 8.77M | 6.71M | 5.85M | 5.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |